ofloxacin has been researched along with 1,2-dipalmitoylphosphatidylcholine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beccari, AR; Fresta, M; Furneri, PM; Guccione, S; Puglisi, G | 1 |
Duan, J; Hayes, D; Li, X; Mansour, HM; Vogt, FG | 1 |
2 other study(ies) available for ofloxacin and 1,2-dipalmitoylphosphatidylcholine
Article | Year |
---|---|
Combining molecular modeling with experimental methodologies: mechanism of membrane permeation and accumulation of ofloxacin.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Biological Transport; Calorimetry, Differential Scanning; Cations, Divalent; Cell Membrane Permeability; Fluoroquinolones; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Lipid Bilayers; Models, Molecular; Ofloxacin; Structure-Activity Relationship | 2002 |
Design, characterization, and aerosolization of organic solution advanced spray-dried moxifloxacin and ofloxacin dipalmitoylphosphatidylcholine (DPPC) microparticulate/nanoparticulate powders for pulmonary inhalation aerosol delivery.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Administration, Inhalation; Aerosols; Anti-Bacterial Agents; Aza Compounds; Desiccation; Drug Carriers; Drug Compounding; Drug Design; Fluoroquinolones; Gases; Moxifloxacin; Nanoparticles; Ofloxacin; Particle Size; Powders; Quinolines; Solutions | 2013 |